← All posts

August 26, 2026

·

6 min read

Natural vs clinical protocol: which one should you actually try first

Every module in a Facet report pairs two non-invasive recommendations with two in-clinic ones. Here is the actual decision framework for choosing between them, based on reversibility and what kind of gap you are closing.

how-tomethodology

Every module in a Facet report ships two lists, not one: two natural protocol recommendations and two clinical protocol recommendations, with no overlap between them. The natural list names something you can start tonight, a specific product, an amount, a timeline. The clinical list names an actual procedure, the typical unit count or session cadence, and the outcome that dose has been shown to produce. Most people open their first report and ask the same question: which list do I actually act on first?

There is no universal answer, but there is a defensible order to work through it, and it has less to do with which list sounds more appealing and more to do with three specific factors: how reversible the intervention is, whether the gap you are closing is soft tissue or skeletal, and how long you are actually willing to wait to see if it worked.

What actually separates the two lists

Natural protocol recommendations are non-invasive and self-administered: topical products, exercises, diet or sleep changes, habits, each with a specific amount and timeline rather than a vague suggestion. Clinical protocol recommendations name an in-clinic aesthetic procedure, injectable, laser, or surgical, with the unit count or session number that produces the stated result. The two lists are built not to overlap, so a report never quietly nudges you toward a procedure for something a topical or a habit change can address on its own.

Reversibility is the first filter

Topical retinoids are the clearest natural protocol example. Mukherjee and colleagues' 2006 review in Clinical Interventions in Aging, covering decades of retinoid trial data, describes measurable improvement in fine lines and skin texture starting around 12 weeks of consistent use, with effects that fade if the product is discontinued. That is a fully reversible intervention: stop using it, and skin returns toward baseline over subsequent months.

Compare that to a clinical protocol entry like masseter botulinum toxin for a jawline module. To and colleagues' 2001 study in the British Journal of Plastic Surgery used ultrasound to confirm measurable masseter muscle thinning after injection, with the muscle rebuilding once the toxin wears off, typically three to four months later. That procedure is also reversible, just on a different clock and at a different cost per cycle. A dermal filler sits further along that scale; it can be dissolved with hyaluronidase, but that is a second procedure, not a natural fade. Surgical entries are the one category with no undo.

Reversibility is not a reason to avoid the clinical list. It is the first thing to check before starting anything on it, because a decision you can reverse if it does not read the way you expected is a lower-stakes decision than one you cannot.

Soft tissue gap versus skeletal gap

The second factor is what is actually driving the score gap in a given module. Skin texture, fine lines, and volume loss are soft tissue changes, and soft tissue generally responds to both lists: a retinoid and a laser resurfacing session are both working on the same tissue, just at different speeds and different depths. A structural measurement like gonial angle or nasal projection is a skeletal or cartilage-driven number. No topical or habit change moves bone. If a module's observation cites a skeletal measurement specifically, the natural protocol entries for that module are working on the soft tissue draped over that structure, not the structure itself, and it is worth reading the observation closely enough to know which one you are looking at.

Cost and cadence belong in the decision too

A natural protocol entry is usually a single purchase repeated daily. A clinical protocol entry is typically a per-session cost that recurs on whatever cycle that procedure wears off, three to four months for a neurotoxin, longer for most fillers. That recurring cost is easy to underweight the first time, since a single session in isolation looks affordable next to a subscription-style skincare routine that also has a monthly cost. Running the actual annualized number for a given clinical recommendation, sessions per year times cost per session, before deciding is a better comparison than looking at either list's single-instance price.

Where this fits in a report

Facet's scoring engine generates exactly two natural and two clinical recommendations per module, specific enough to name a product and amount or a procedure and unit count, honest enough to avoid defaulting to surgery when a habit change covers the same gap. Reading which category a given module's gap actually falls into, soft tissue or skeletal, is the fastest way to know which of the two lists to start with. A full example report showing both lists across all ten modules is posted at [/sample-report](/sample-report), and pricing for a full scan is at [/pricing](/pricing).

More reading